Lynozyfic 61755-0056

Generic: Linvoseltamab-Gcpt

Product NDC

61755-0056

Manufacturer: Regeneron Pharmaceuticals, Inc.
Dosage Form: Injection, Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: July 2, 2025
Listing Expires: December 31, 2026
Application: BLA761400

Need to source Lynozyfic? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Linvoseltamab	200 mg/10mL

Drug Class

Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]

Packaging Options(1)

61755-0056-01

1 VIAL, SINGLE-DOSE in 1 CARTON (61755-056-01) / 10 mL in 1 VIAL, SINGLE-DOSE (61755-056-00)

View →